International Research Journal of Commerce , Arts and Science

 ( Online- ISSN 2319 - 9202 )     New DOI : 10.32804/CASIRJ

Impact Factor* - 6.2311


**Need Help in Content editing, Data Analysis.

Research Gateway

Adv For Editing Content

   No of Download : 106    Submit Your Rating     Cite This   Download        Certificate

FORMULATION AND EVALAUTION OF ORODISPERSIBLE TABLET OF MONTELUKAST AND BILASTINE

    2 Author(s):  DEEPAK SINGH ,DR.G.GNANARAJAN

Vol -  13, Issue- 12 ,         Page(s) : 33 - 49  (2022 ) DOI : https://doi.org/10.32804/CASIRJ

Abstract

Montelukast+ Bilastine orodispersible tablets are prepared to manifest once daily oral combinations are given to patients with seasonal allergic rhinitis, mild to moderate asthma and Rhinoconjuctivitis. The recent research work was aimed to formulate the orodispersible tablet of montelukast (10mg) and Bilastine (20mg) by using super disintegrants i.e Cross povidone and Crosscarmellose

Dey P, Maiti S. Orodispersible tablets: A new trend in drug delivery J Nat Sci Biol Med. 2010 Jul-Dec; 1(1): 2–5.
Lachman L, Herbert A. Lieberman, Joseph L. Kanig: The theory and Practice of Industrial Pharmacy, Varghese publication house, 3rd edition, 1990, 293-373.
Herbert A. Liberman, Martin M. Rieger and Gilbert S. Banker, pharmaceutical dosage forms: Tablets; volume-I

*Contents are provided by Authors of articles. Please contact us if you having any query.






Bank Details